Skip to main navigation Skip to search Skip to main content

A mainstreaming oncogenomics model: improving the identification of Lynch syndrome

  • Rosie O’Shea
  • , Ashley Crook
  • , Chris Jacobs
  • , Maira Kentwell
  • , Margaret Gleeson
  • , Katherine M. Tucker
  • , Heather Hampel
  • , Alanna Kulchak Rahm
  • , Natalie Taylor
  • , Sarah Lewis
  • , Nicole M. Rankin
  • University of Sydney
  • University of Technology Sydney
  • Peter Maccallum Cancer Centre
  • Royal Women's Hospital
  • Hunter Genetics
  • Prince of Wales Hospital
  • City of Hope National Med Center
  • Geisinger
  • Cancer Council NSW
  • University of Melbourne

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Introduction: "Mainstreaming" is a proposed strategy to integrate genomic testing into oncology. The aim of this paper is to develop a mainstreaming oncogenomics model by identifying health system interventions and implementation strategies for mainstreaming Lynch syndrome genomic testing. Methods: A rigorous theoretical approach inclusive of conducting a systematic review and qualitative and quantitative studies was undertaken using the Consolidated Framework for Implementation Research. Theory-informed implementation data were mapped to the Genomic Medicine Integrative Research framework to generate potential strategies. Results: The systematic review identified a lack of theory-guided health system interventions and evaluation for Lynch syndrome and other mainstreaming programs. The qualitative study phase included 22 participants from 12 health organizations. The quantitative Lynch syndrome survey included 198 responses: 26% and 66% from genetic and oncology health professionals, respectively. Studies identified the relative advantage and clinical utility of mainstreaming to improve genetic test access and to streamline care, and adaptation of current processes was recognized for results delivery and follow-up. Barriers identified included funding, infrastructure and resources, and the need for process and role delineation. The interventions to overcome barriers were as follows: embedded mainstream genetic counselors, electronic medical record genetic test ordering, results tracking, and mainstreaming education resources. Implementation evidence was connected through the Genomic Medicine Integrative Research framework resulting in a mainstreaming oncogenomics model. Discussion: The proposed mainstreaming oncogenomics model acts as a complex intervention. It features an adaptable suite of implementation strategies to inform Lynch syndrome and other hereditary cancer service delivery. Implementation and evaluation of the model are required in future research.
Original languageEnglish
Article number1140135
Number of pages10
JournalFrontiers in Oncology
Volume13
DOIs
Publication statusPublished - 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2023 O’Shea, Crook, Jacobs, Kentwell, Gleeson, Tucker, Hampel, Rahm, Taylor, Lewis and Rankin.

Open Access - Access Right Statement

© 2023 O’Shea, Crook, Jacobs, Kentwell, Gleeson, Tucker, Hampel, Rahm, Taylor, Lewis and Rankin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Lynch syndrome
  • mainstreaming
  • oncogenomics model
  • oncology service delivery
  • routine genetic testing

Fingerprint

Dive into the research topics of 'A mainstreaming oncogenomics model: improving the identification of Lynch syndrome'. Together they form a unique fingerprint.

Cite this